The Beirne B. Carter Lecture in Immunology was established to bring a distinguished medical scientist each year to the UVA Health System.  In keeping with Mr. Carter’s vision, the scientist is chosen based on his or her research accomplishments contributing to the areas of basic and clinical immunology and to our understanding of human disease and its cure.

Past Beirne B. Carter Annual Lectures

2003

Ralph Steinman, MD, PhD
Department of Cell Physiology and Immunology, Rockefeller University
The control of immunity and tolerance by dendritic cells

2002

Gerald R. Crabtree, MD
Professor of Pathology and Developmental Biology, Stanford University School of Medicine
Converting graded signals to discrete developmental outcomes

2001

Philippa Marrack, PhD
Investigator, Department of Immunology, Howard Hughes Medical Institute, National Jewish Medical and Research Center
T cell life, death and memory

2000

Paul M. Allen, PhD
Robert L. Kroc Professor of Pathology & Immunology, Department of Pathology & Immunology, Washington University
Physiology of Tumor Rejection: Insights from a Transgenic Model

1999

Craig Thompson, MD
Director, Madlyn Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center
Control of lymphocyte survival: implications for lymphocytes in health and disease

1998

Roger M. Perlmutter, MD, PhD
Senior Vice President of Research, Merck & Co., Inc.
The LNK Family of Signal Transducing Molecules

1997

Peter C. Doherty, PhD
St Jude’s Children Research Hospital
Immunity to a Persistent Gamma Herpesvirus

1996

Klaus Rajewsky, MD
Institute for Genetics, University of Cologne
Genetic Approaches to the Study of Normal and Malignant B Cell Development

1995

Richard Klauser, MD
Chief, Cell Biology abd Metabolism Branch, National Institutes of Child Health and Development
A Cell Biologist Looks at the T Cell Receptor

1993

Leroy Hood, MD, PhD
University of Washington School of Medicine
T Cell Receptors: Molecular Recognition and Autoimmunity

1992

Hugh O. McDevitt, MD
Stanford University School of Medicine
Peptide Interactions with Class II MHC Molecules in Experimental Allergic Encephalomyelitis